about kinex

Kinex Pharmaceuticals - Buffalo NY Biotechnology Company

Kinex is a specialty pharmaceutical company focused on the development and commercialization of next generation therapies for cancer and immunomodulatory diseases.

Our Company >>

clinical trials

Kinex Pharmaceuticals Clinical Trials

Kinex has numerous clinical oncology studies underway or in the planning stage.

Clinical Trials >>


Kinex Completes Acquisition of QuaDPharma Tuesday, September 9th, 2014

• Adds GLP and cGMP Capabilities to Kinex Platform • Generates Opportunity to Execute Against Global Manufacturing Opportunities Kinex Pharmaceuticals Inc. today

Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) Thursday, July 24th, 2014

Kinex Pharmaceuticals announced the receipt of an allowance by the US FDA for the Company’s KX2-391 Ointment for the commencement of a

News/Events >>